Q BioMed Inc

Q BioMed Inc. is a biotech company based in New York, New York. The company is a small company with 6 employees. Q BioMed Inc. focuses on licensing and acquiring undervalued biomedical assets in the healthcare sector. Their mission is to provide these assets with the resources, development support, and funding necessary to reach their full potential and deliver products to patients. Q BioMed is dedicated to accelerating the development and commercialization of promising biomedical technologies. They aim to identify undervalued assets with high therapeutic potential and work closely with inventors and researchers to bring them to market. For more information about Q BioMed Inc. and their offerings, please visit their website at qbiomed.com.

Q BioMed Inc. is a biotechnology company specializing in acquiring, developing, and financing undervalued biomedical assets. The company's primary focus is on building a pipeline of innovative biomedical assets across various stages of development, targeting multiple therapeutic areas. Q BioMed Inc. operates with the goal of minimizing risk, sharing success, and accelerating technologies from incubation to monetization. The company is located at 366 Madison Avenue, 3rd Floor, New York, NY 10017. Q BioMed Inc. has been operating in the biomedical field for over 13 years. The company's contact information includes a phone number, +1(646) 889-2226, and an email address, [email protected]. Q BioMed Inc. does not directly offer specific products or services, but rather focuses on the development and financing of biomedical assets. The company's activities encompass the acquisition, development, and financial support of these assets. The company's approach involves bringing these assets through various stages of development, with the ultimate goal of achieving monetization. Q BioMed Inc. targets the healthcare, biotechnology, and pharmaceutical industries. The company's expertise in business and product development, along with its strong network of strategic partners and experts, supports its operations within these sectors. Q BioMed Inc. concentrates on value-driven assets, ranging from early-stage ventures to businesses nearing revenue generation. Q BioMed Inc. possesses several competitive advantages. These include over 13 years of experience in the biomedical field, expertise in business and product development, and a robust network of strategic partners and experts. The company's focus on value-driven assets, from early-stage to near-revenue businesses, further distinguishes its approach. Q BioMed Inc. is guided by core values that include innovation, risk minimization, value creation, and strategic partnerships. The company is led by CEO and Chairman Denis D Corin, with William Rosenstadt serving as General Counsel and Director. Other key personnel include Dr. Rick Panicucci as Director and Advisor, Pharmaceutical Development; Ari Jatwes as Director, Finance; and David Laskow-Pooley as Scientific Advisor.